California State Teachers Retirement System Vaxart, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.71 - $1.25 $2,503 - $4,407	-3,526 Reduced 6.87%	47,806 $36,000
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $79,771 - $238,250	-106,362 Reduced 67.45%	51,332 $49,000
Q3 2022 Nov 18, 2022	SELL	$2.09 - $4.5 $3,239 - $6,975	-1,550 Reduced 0.97%	157,694 $344,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $2,135 - $4,176	-791 Reduced 0.49%	159,244 $557,000
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $44,513 - $68,896	-10,376 Reduced 6.09%	160,035 $807,000
Q4 2021 Feb 15, 2022	BUY	$5.77 - $7.96 $33,910 - $46,780	5,877 Added 3.57%	170,411 $1.07 Million
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $1,827 - $2,685	-274 Reduced 0.17%	164,534 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $434,153 - $924,934	85,801 Added 108.6%	164,808 $1.23 Million
Q1 2021 May 18, 2021	SELL	$5.64 - $23.33 $1,607 - $6,649	-285 Reduced 0.36%	79,007 $478,000
Q3 2020 Nov 17, 2020	BUY	$4.78 - $16.97 $58,072 - $206,168	12,149 Added 18.09%	79,292 $527,000
Q2 2020 Aug 17, 2020	BUY	$1.68 - $8.85 $112,800 - $594,215	67,143 New	67,143 $594,000

Others Institutions Holding VXRT

# of Institutions

110

Shares Held

37.6M

Call Options Held

188K

Put Options Held

180K

Sio Capital Management, LLC New York, NY

13.6M
Shares

$7.89 Million
6.11% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$5.84 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.97M
Shares

$2.3 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.54M
Shares

$1.48 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.77M
Shares

$1.03 Million
0.0% of portfolio

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account